Prime Medicine, Inc.
NASDAQPRME heads into its June 5 earnings call with short positioning at its most crowded level in months and the borrow market tightening sharply — a setup that puts maximum pressure on whatever the company delivers next week. Short interest has climbed steadily, reaching 29.4% of the free float. That is up from roughly 27.7% a month ago and marks the highest level in the 30-day window…
Snapshot as of 27 May 2026
PRME heads into its June 5 earnings call with short positioning at its most crowded level in months and the borrow market tightening sharply — a setup that puts maximum pressure on whatever the company delivers next…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PRME — free to start on ORTEX.
Sign up for free →Open PRME on ORTEX